Pg 66 | Cover Story

The Reality Check: Why ESG in Pharma Must Now Prove its Value

Pg 66 | Cover Story

The Reality Check: Why ESG in Pharma Must Now Prove its Value

Pharma Now

Beyond CSR- ESG Moves Into Boardrooms

FEATURING

    • Cover Story: ESG in Pharma.
    • In Talks with Leadership: Featuring Mr. Abhay Kumar Srivastava
    • Market Insights: Packaging transformation &  AI-led drug repurposing.
    • Startup & Innovation: How GenepoweRx is transforming the genomic landscape.
    • Manufacturing: Biocatalysis, automation, digital labs, and smart pharma operations.
Get a glimpse

Section Overview

Cover Story

Pharma Now

The Reality Check: Why ESG in Pharma Must Now Prove its Value

A strategic look at how ESG reporting is reshaping pharma leadership, governance, and regulatory credibility worldwide.

MAGAZINE ARTICLE by Mrudula Kulkarni

Ad
Advertisement
News Letter

Subscribe to our Newsletter!

Be the first to get exclusive offers and the latest news